首页> 外文期刊>Journal of gastroenterology and hepatology >Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea‐predominant irritable bowel syndrome
【24h】

Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea‐predominant irritable bowel syndrome

机译:Duodenal和直肠粘膜微生物与腹泻的小肠细菌过度生长有关,腹泻主要肠易激综合征

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background and Aim Small intestinal bacterial overgrowth (SIBO) has been proposed as an etiologic factor in irritable bowel syndrome, particularly the diarrhea‐predominant subtype (IBS‐D). We aimed to identify potential intestinal microbial pattern in IBS‐D patients with SIBO. Methods Diarrhea‐predominant irritable bowel syndrome patients fulfilling Rome III criteria were recruited and randomly divided into an exploratory cohort (57 cases) and a validation cohort (20 cases). SIBO was identified according to standard glucose hydrogen breath test. For 16S rRNA gene sequencing, samples of duodenal mucosa, duodenal fluid, rectal mucosa, and fresh feces were collected and performed. The α and β diversity, as well as differences in microbial composition and function, in SIBO + and SIBO ? IBS‐D subjects were evaluated. Results The microbial diversity and composition obviously differed between SIBO + and SIBO ? IBS‐D in duodenal and rectal mucosa but not in duodenal fluid and fresh feces. For rectal mucosal microbiota, it displayed markedly reduced aerobe and Gram‐negative bacteria and increased facultative anaerobe and Gram‐positive bacteria, moreover, altered functions of microbial metabolism in SIBO + IBS‐D. Significantly higher rectal mucosa‐related microbial dysbiosis index was observed in SIBO + IBS‐D, and a cut‐off value at ?0.37 had a sensitivity of 56.55% and specificity of 90.91% to identify the SIBO in IBS‐D subjects. Conclusions Mucosal microbiota, rather than luminal bacteria, has a more apparent dysbiosis in SIBO + IBS‐D patients relative to those without SIBO. Rectal mucosa‐associated microbiota may act as a potential predictor of SIBO in IBS‐D patients.
机译:摘要背景和目的小肠细菌过度生长(SIBO)已被提出作为肠易激综合征的病因因素,特别是腹泻主要亚型(IBS-D)。我们旨在识别SIBO患者IBS-D患者的潜在肠道微生物模式。方法腹泻急性肠易激综合征患者招募罗马III标准,随机分为探索队列(57例)和验证队列(20例)。根据标准葡萄糖氢气呼吸试验鉴定SIBO。对于16S rRNA基因测序,收集并进行十二指肠粘膜样品,十二指肠流体,直肠粘膜和新鲜粪便。 α和β多样性,以及微生物组成和功能的差异,在sibo +和sibo中?评估IBS-D受试者。结果SIBO +和SIBO之间的微生物多样性和组成明显不同?在十二指肠和直肠粘膜中的IBS-D,但不是十二指肠液和新鲜粪便。对于直肠粘膜微生物,它显示出明显减少的环境和革兰氏阴性细菌,以及增加的剖腹产和革兰氏阳性细菌,以及SIBO + IBS-D中微生物代谢的改变功能。在SIBO + IBS-D中观察到明显较高的直肠粘膜相关的微生物脱蛋白指数,截止值Δ0.37的敏感性为56.55%,特异性为90.91%,以鉴定IBS-D受试者中的SIBO。结论粘膜微生物,而不是腔细菌,在SIBO + IBS-D患者中具有更明显的困难,相对于没有SIBO的患者。直肠粘膜相关的微生物群可以作为IBS-D患者SIBO的潜在预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号